Clinical Trial Update: Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of a bisphosphonate on bone loss in postmenopausal women with breast cancer initiating aromatase inhibitor therapy; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Drugs mentioned

• Bisphosphonate

Snippet

Sponsor: Susan L. Greenspan | Conditions: Bone Loss, Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2014-07-03